HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Ashford Capital Management Inc.

Ashford Capital Management Inc. cut its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 269,312 shares of the company's stock after selling 35,910 shares during the period. HealthEquity accounts for approximately 3.0% of Ashford Capital Management Inc.'s investment portfolio, making the stock its 10th largest holding. Ashford Capital Management Inc. owned 0.31% of HealthEquity worth $25,840,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Arcadia Investment Management Corp MI acquired a new position in HealthEquity during the 4th quarter worth $26,000. Transce3nd LLC acquired a new stake in HealthEquity in the fourth quarter worth about $29,000. Smartleaf Asset Management LLC grew its position in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares in the last quarter. Proficio Capital Partners LLC bought a new position in HealthEquity in the 4th quarter valued at about $39,000. Finally, UMB Bank n.a. increased its stake in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on HQY. KeyCorp decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. The Goldman Sachs Group decreased their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Barrington Research restated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, April 11th. Finally, Wells Fargo & Company boosted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $111.75.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company's stock, valued at $6,597,842.85. This trade represents a 6.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Trading Down 0.6%

HealthEquity stock opened at $97.60 on Tuesday. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $8.44 billion, a price-to-earnings ratio of 89.54, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a 50 day moving average price of $87.92 and a 200 day moving average price of $97.20.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.